Kristensen S, Tveteraas K, Hein P, Poulsen H B, Outzen K E
ENT Department, St. Joseph's Hospital, Esbjerg, Denmark.
J Laryngol Otol. 1988 Jan;102(1):39-42. doi: 10.1017/s0022215100103913.
The pain-relieving efficacy of naproxen and acetylsalicylic acid (ASA) in tonsillectomized patients was compared in a double blind parallel clinical trial comprising 83 patients, among whom 42 were treated with naproxen and 41 with ASA. The patients were treated post-operatively for two days with either naproxen suppositories 500 mg. twice, or ASA effervescent tablets 1000 mg. three times, daily. The therapeutic gain was evaluated by recording the intensity of pain, reduced ability to open the mouth (trismus), consumption of supplementary analgesic (parcetamol), and pain-related sleep disturbances. The statistical analysis of the results revealed no differences in pain intensity, consumption of additional analgesics or pain-related sleep disturbances in the two treatment groups. A considerable degree of trismus was demonstrated in most of the tonsillectomized patients. This reduced ability to open the mouth was gradually overcome in the naproxen group while it remained unchanged in the ASA group, however, no statistical significant difference could be demonstrated. Additionally, no significant positive correlation between pain intensity and trismus was proven. The pain-relieving effect, however, was unsatisfactory in both the naproxen and the ASA group, and clinical controlled trial studies of alternative analgetics in tonsillectomized patients are still to be encouraged.
在一项纳入83例患者的双盲平行临床试验中,比较了萘普生和乙酰水杨酸(ASA)对扁桃体切除患者的止痛效果,其中42例患者接受萘普生治疗,41例接受ASA治疗。术后两天,患者分别接受500毫克萘普生栓剂,每日两次,或1000毫克ASA泡腾片,每日三次治疗。通过记录疼痛强度、张口受限(牙关紧闭)情况、辅助镇痛药(对乙酰氨基酚)的使用量以及与疼痛相关的睡眠障碍来评估治疗效果。结果的统计分析显示,两个治疗组在疼痛强度、额外镇痛药的使用量或与疼痛相关的睡眠障碍方面没有差异。大多数扁桃体切除患者表现出相当程度的牙关紧闭。在萘普生组中,这种张口受限的情况逐渐得到缓解,而在ASA组中则保持不变,然而,未显示出统计学上的显著差异。此外,未证实疼痛强度与牙关紧闭之间存在显著的正相关。然而,萘普生组和ASA组的止痛效果均不令人满意,仍鼓励对扁桃体切除患者使用替代镇痛药进行临床对照试验研究。